Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Development Of Precision Medicine
3.2. Key Drivers
3.2.1. Usage Of Digital Collaboration In Exchanging Useful Information For Developingg Precision Medicine
3.2.2. Identification And Characterization Of Essential Genes In The Human Genome
3.2.3. Prevalence Of Precision Medicine To Tackle Chronic Conditions
3.2.4. Demand For Preventive Care
3.3. Key Restraints
3.3.1. Security Risks Associated With Data Sharing
3.3.2. Uncertainty Associated With Reimbursement And Regulatory Policies

4. Key Analytics
4.1. Impact Of Covid-19 On Precision Medicine Market
4.2. Key Investment Insights
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entries
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Technologies Related To Precision Medicine
4.7. Supply Chain Analysis

5. Market By Application
5.1. Oncology
5.2. Infectious Diseases
5.3. Neurology/Physiatry
5.4. Cardiovascular
5.5. Lifestyle And Endocrinology
5.6. Gastroenterology
5.7. Other Applications

6. Market By Component
6.1. Applied Science
6.1.1. Genomics
6.1.1.1. Pcr
6.1.1.2. Pm Ngs
6.1.1.3. Genome Editing
6.1.1.4. Other Genomics Technologies
6.1.2. Pharmacogenomics
6.1.3. Other Applied Sciences
6.2. Precision Therapeutics
6.2.1. Clinical Trials
6.2.2. Cell Therapy
6.2.3. Drug Discovery And Research
6.2.4. Gene Therapy
6.3. Precision Diagnostics
6.3.1. Molecular Diagnostics
6.3.1.1. Non-Invasive Prenatal Testing (Nipt)
6.3.1.2. Companion Diagnostics
6.3.1.3. Liquid Biopsy
6.3.1.4. Other Molecular Diagnostics
6.3.2. Medical Imaging
6.3.2.1. Imaging Analytics
6.3.2.2. Imaging Computer-Aided Detection (Cadx)
6.4. Digital Health And Information Technology
6.4.1. Clinical Decision Support Systems (Cdss)
6.4.2. Big Data Analytics
6.4.3. It Infrastructure
6.4.4. Genomics Informatics
6.4.5. In-Silico Informatics
6.4.6. Mobile Health

7. Geographical Analysis
7.1. Asia-Pacific
7.1.1. Market Size & Estimates
7.1.2. Key Growth Enablers
7.1.3. Key Challenges
7.1.4. Key Players
7.1.5. Country Analysis
7.1.5.1. China
7.1.5.2. Japan
7.1.5.3. Australia & New Zealand
7.1.5.4. India
7.1.5.5. South Korea
7.1.5.6. Thailand
7.1.5.7. Malaysia
7.1.5.8. Singapore
7.1.5.9. Rest Of Asia-Pacific

8. Competitive Landscape
8.1. Key Strategic Developments
8.1.1. Mergers & Acquisitions
8.1.2. Product Launches & Developments
8.1.3. Partnerships, Contracts/Agreements & Collaborations
8.1.4. Business Expansions/ Approvals/ Announcements
8.2. Company Profiles
8.2.1. Abbott Laboratories
8.2.2. Astra Zeneca Plc
8.2.3. Biocrates Life Sciences Ag
8.2.4. Bio-Rad Laboratories Inc
8.2.5. Danaher Corporation
8.2.6. Eagle Genomics Ltd
8.2.7. Eli Lilly & Company
8.2.8. F. Hoffmann-La Roche
8.2.9. Intomics
8.2.10. Laboratory Corporation Of America Holdings
8.2.11. Nanostring Technologies
8.2.12. Novartis Ag
8.2.13. Pfizer Inc
8.2.14. Qiagen Nv
8.2.15. Quest Diagnostics Incorporated



List of Figures


Figure 1: Key Investment Insights
Figure 2: Porter’S Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Asia-Pacific Precision Medicine Market, By Application, In 2020
Figure 6: Asia-Pacific Precision Medicine Market, By Oncology, 2021-2028 (In $ Million)
Figure 7: Asia-Pacific Precision Medicine Market, By Infectious Diseases, 2021-2028 (In $ Million)
Figure 8: Asia-Pacific Precision Medicine Market, By Neurology/Physiatry, 2021-2028 (In $ Million)
Figure 9: Asia-Pacific Precision Medicine Market, By Cardiovascular, 2021-2028 (In $ Million)
Figure 10: Asia-Pacific Precision Medicine Market, By Lifestyle And Endocrinology, 2021-2028 (In $ Million)
Figure 11: Asia-Pacific Precision Medicine Market, By Gastroenterology, 2021-2028 (In $ Million)
Figure 12: Asia-Pacific Precision Medicine Market, By Other Applications,2021-2028 (In $ Million)
Figure 13: Asia-Pacific Precision Medicine Market, By Component, In 2020
Figure 14: Asia-Pacific Precision Medicine Market, By Applied Science, 2021-2028 (In $ Million)
Figure 15: Asia-Pacific Applied Science Market, By Genomics, 2021-2028 (In $ Million)
Figure 16: Asia-Pacific Genomics Market, By Pcr, 2021-2028 (In $ Million)
Figure 17: Asia-Pacific Genomics Market, By Pm Ngs, 2021-2028 (In $ Million)
Figure 18: Asia-Pacific Genomics Market, By Genome Editing, 2021-2028 (In $ Million)
Figure 19: Asia-Pacific Genomics Market, By Other Genomics Technologies, 2021-2028 (In $ Million)
Figure 20: Asia-Pacific Applied Science Market, By Pharmacogenomics, 2021-2028 (In $ Million)
Figure 21: Biomarker’S Role In Pharmacogenomics
Figure 22: Asia-Pacific Applied Sciences Market, By Other Applied Sciences, 2021-2028 (In $ Million)
Figure 23: Asia-Pacific Precision Medicine Market, By Precision Therapeutics, 2021-2028 (In $ Million)
Figure 24: Asia-Pacific Precision Therapeutics Market, By Clinical Trials, 2021-2028 (In $ Million)
Figure 25: Asia-Pacific Precision Therapeutics Market, By Cell Therapy, 2021-2028 (In $ Million)
Figure 26: Asia-Pacific Precision Therapeutics Market, By Drug Discovery And Research, 2021-2028 (In $ Million)
Figure 27: Asia-Pacific Precision Therapeutics Market, By Gene Therapy, 2021-2028 (In $ Million)
Figure 28: Asia-Pacific Precision Medicine Market, By Precision Diagnostics, 2021-2028 (In $ Million)
Figure 29: Asia-Pacific Precision Diagnostics Market, By Molecular Diagnostics, 2021-2028 (In $ Million)
Figure 30: Asia-Pacific Molecular Diagnostics Market, By Non-Invasive Prenatal Testing (Nipt), 2021-2028 (In $ Million)
Figure 31: Asia-Pacific Molecular Diagnostics Market, By Companion Diagnostics, 2021-2028 (In $ Million)
Figure 32: Asia-Pacific Molecular Diagnostics Market, By Liquid Biopsy, 2021-2028 (In $ Million)
Figure 33: Asia-Pacific Molecular Diagnostics Market, By Other Molecular Diagnostics, 2021-2028 (In $ Million)
Figure 34: Asia-Pacific Precision Diagnostics Market, By Medical Imaging, 2021-2028 (In $ Million)
Figure 35: Asia-Pacific Medical Imaging Market, By Imaging Analytics, 2021-2028 (In $ Million)
Figure 36: Asia-Pacific Medical Imaging Market, By Imaging Computer-Aided Detection (Cadx), 2021-2028 (In $ Million)
Figure 37: Asia-Pacific Precision Medicine Market, By Digital Health And Information Technology, 2021-2028 (In $ Million)
Figure 38: Asia-Pacific Digital Health And Information Technology Market, By Clinical Decision Support Systems (Cdss), 2021-2028 (In $ Million)
Figure 39: Asia-Pacific Digital Health And Information Technology Market, By Big Data Analytics, 2021-2028 (In $ Million)
Figure 40: Asia-Pacific Digital Health And Information Technology Market, By It Infrastructure, 2021-2028 (In $ Million)
Figure 41: Asia-Pacific Digital Health And Information Technology Market, By Genomics Informatics, 2021-2028 (In $ Million)
Figure 42: Asia-Pacific Digital Health And Information Technology Market, By In-Silico Informatics, 2021-2028 (In $ Million)
Figure 43: Asia-Pacific Digital Health And Information Technology Market, By Mobile Health, 2021-2028 (In $ Million)
Figure 44: Asia-Pacific Precision Medicine Market, Country Outlook, 2020 & 2028 (In %)
Figure 45: China Precision Medicine Market, 2021-2028 (In $ Million)
Figure 46: Japan Precision Medicine Market, 2021-2028 (In $ Million)
Figure 47: Australia & New Zealand Precision Medicine Market, 2021-2028 (In $ Million)
Figure 48: India Precision Medicine Market, 2021-2028 (In $ Million)
Figure 49: South Korea Precision Medicine Market, 2021-2028 (In $ Million)
Figure 50: Thailand Precision Medicine Market, 2021-2028 (In $ Million)
Figure 51: Malaysia Precision Medicine Market, 2021-2028 (In $ Million)
Figure 52: Singapore Precision Medicine Market, 2021-2028 (In $ Million)


List of Tables


TABLE 1: MARKET SNAPSHOT - PRECISION MEDICINE
TABLE 2: ASIA-PACIFIC PRECISION MEDICINE MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: ASIA-PACIFIC PRECISION MEDICINE MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC PRECISION MEDICINE MARKET, BY COMPONENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC PRECISION MEDICINE MARKET, BY COMPONENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC APPLIED SCIENCE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC APPLIED SCIENCE MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC GENOMICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC GENOMICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC PRECISION THERAPEUTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC PRECISION THERAPEUTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC PRECISION DIAGNOSTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: ASIA-PACIFIC PRECISION DIAGNOSTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 15: ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 16: ASIA-PACIFIC MEDICAL IMAGING MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 17: ASIA-PACIFIC MEDICAL IMAGING MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 18: ASIA-PACIFIC DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 19: ASIA-PACIFIC DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION
TABLE 20: ASIA-PACIFIC PRECISION MEDICINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 21: ASIA-PACIFIC PRECISION MEDICINE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 22: LEADING PLAYERS OPERATING IN ASIA-PACIFIC PRECISION MEDICINE MARKET
TABLE 23: LIST OF MERGERS & ACQUISITIONS
TABLE 24: LIST OF PRODUCTS LAUNCHES & DEVELOPMENTS
TABLE 25: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 26: LIST OF BUSINESS EXPANSIONS & DIVESTITURES